Translational Fellowships: Perspectives from a BMS mentor and 5 Oxford-BMS Fellows
Professor Anjan Thakurta, Vice President, Translational Development Disease Teams (Heme Cancers), is trained as a molecular biologist and conducted basic and translational research in the last two decades working in cancer biology and translational development of therapies in hematological malignancies. During the last five years, he led large collaborative projects in decoding the Myeloma Genome and establishing the largest database in this disease. He takes a reverse translational approach in his research in using patient derived data to guide the development of scientific hypotheses. His current research interests are understanding the genetic, epigenetic and immune mechanisms that drive high risk disease and therapeutic resistance in Multiple Myeloma and other hematological malignancies and the discovery and development of new therapeutics.
Anjan is a Visiting Professor of Cancer Biology and Translational Medicine at Oxford and works closely with Fellows as part of the Oxford-Bristol Myers Squibb (BMS) Fellowships Programme and he along with five fellows will talk about their experiences.
2 November 2021, 12:00 (Tuesday, 4th week, Michaelmas 2021)
Anjan Thakurta (Celgene)
Medical Sciences Office
Sheena Lee (MSD Business Partnerships Office),
Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address:
Dr Charlotte Bell (Industry Partnerships Manager, University of Oxford)
Industry Insight Seminar Series
Members of the University of Oxford and the Biotech/Pharma industry